ETHK Labs Inc. (HKG:1931)

Market Cap	962.57M -92.7%
Revenue (ttm)	3.14B -10.8%
Net Income	38.87M -86.6%
EPS	0.02 -87.6%
Shares Out	1.60B
PE Ratio	25.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,000
Open	0.6100
Previous Close	0.5900
Day's Range	0.5950 - 0.6100
52-Week Range	0.5600 - 11.9600
Beta	-0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 910
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1931

Financial Performance

In 2025, ETHK Labs's revenue was 2.82 billion, a decrease of -10.81% compared to the previous year's 3.16 billion. Earnings were 34.93 million, a decrease of -86.59%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error